Industry Research Reports

Home > Reports > Medical Devices & Consumables > Chitosan Hemostatic Material- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Chitosan Hemostatic Material- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-10-17

Pages: 130 Pages

Report ld: 3348338

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Chitosan hemostatic materials are a type of biomedical materials based on natural chitosan, which are mainly used to accelerate hemostasis and promote wound healing. Chitosan is a natural polysaccharide extracted from the shells of crustaceans, which has good biocompatibility, antibacterial and degradability. Its hemostatic mechanism includes promoting platelet aggregation, accelerating blood clot formation and constricting blood vessels. Chitosan hemostatic materials are widely used in surgical operations, trauma emergency treatment and the treatment of chronic trauma, and have multiple functions of rapid hemostasis, reducing infection and promoting tissue repair.

The global market for Chitosan Hemostatic Material was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

North American market for Chitosan Hemostatic Material was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Chitosan Hemostatic Material was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Chitosan Hemostatic Material was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Chitosan Hemostatic Material include Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, Hemostasis, Medcura, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Chitosan Hemostatic Material, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chitosan Hemostatic Material by region & country, by Type, and by Application.

The Chitosan Hemostatic Material market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chitosan Hemostatic Material.

MARKET SEGMENTATION

By Company

Anscare
Tricol Biomedical
Advamedica
Hemoflex
Mermaid Medical
Hemostasis
Medcura
BioPharm Med
MedTrade Products
Shijiazhuang Yishengtang Medical Product
Biotemed
Haiyuan Hairun
Yancheng Yankang Medical Equipment
Success Bio-Tech
Lanhine Medical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Hemostatic Gauze
Hemostatic Powder
Hemostatic Sponge
Others

Segment by Application

Surgery
First Aid

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Chitosan Hemostatic Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Chitosan Hemostatic Material in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Chitosan Hemostatic Material in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Chitosan Hemostatic Material Product Introduction

1.2 Global Chitosan Hemostatic Material Market Size Forecast

1.2.1 Global Chitosan Hemostatic Material Sales Value (2019-2030)

1.2.2 Global Chitosan Hemostatic Material Sales Volume (2019-2030)

1.2.3 Global Chitosan Hemostatic Material Sales Price (2019-2030)

1.3 Chitosan Hemostatic Material Market Trends & Drivers

1.3.1 Chitosan Hemostatic Material Industry Trends

1.3.2 Chitosan Hemostatic Material Market Drivers & Opportunity

1.3.3 Chitosan Hemostatic Material Market Challenges

1.3.4 Chitosan Hemostatic Material Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Chitosan Hemostatic Material Players Revenue Ranking (2023)

2.2 Global Chitosan Hemostatic Material Revenue by Company (2019-2024)

2.3 Global Chitosan Hemostatic Material Players Sales Volume Ranking (2023)

2.4 Global Chitosan Hemostatic Material Sales Volume by Company Players (2019-2024)

2.5 Global Chitosan Hemostatic Material Average Price by Company (2019-2024)

2.6 Key Manufacturers Chitosan Hemostatic Material Manufacturing Base and Headquarters

2.7 Key Manufacturers Chitosan Hemostatic Material Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Chitosan Hemostatic Material

2.9 Chitosan Hemostatic Material Market Competitive Analysis

2.9.1 Chitosan Hemostatic Material Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Chitosan Hemostatic Material Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chitosan Hemostatic Material as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Hemostatic Gauze

3.1.2 Hemostatic Powder

3.1.3 Hemostatic Sponge

3.1.4 Others

3.2 Global Chitosan Hemostatic Material Sales Value by Type

3.2.1 Global Chitosan Hemostatic Material Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Chitosan Hemostatic Material Sales Value, by Type (2019-2030)

3.2.3 Global Chitosan Hemostatic Material Sales Value, by Type (%) (2019-2030)

3.3 Global Chitosan Hemostatic Material Sales Volume by Type

3.3.1 Global Chitosan Hemostatic Material Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Chitosan Hemostatic Material Sales Volume, by Type (2019-2030)

3.3.3 Global Chitosan Hemostatic Material Sales Volume, by Type (%) (2019-2030)

3.4 Global Chitosan Hemostatic Material Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Surgery

4.1.2 First Aid

4.2 Global Chitosan Hemostatic Material Sales Value by Application

4.2.1 Global Chitosan Hemostatic Material Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Chitosan Hemostatic Material Sales Value, by Application (2019-2030)

4.2.3 Global Chitosan Hemostatic Material Sales Value, by Application (%) (2019-2030)

4.3 Global Chitosan Hemostatic Material Sales Volume by Application

4.3.1 Global Chitosan Hemostatic Material Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Chitosan Hemostatic Material Sales Volume, by Application (2019-2030)

4.3.3 Global Chitosan Hemostatic Material Sales Volume, by Application (%) (2019-2030)

4.4 Global Chitosan Hemostatic Material Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Chitosan Hemostatic Material Sales Value by Region

5.1.1 Global Chitosan Hemostatic Material Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Chitosan Hemostatic Material Sales Value by Region (2019-2024)

5.1.3 Global Chitosan Hemostatic Material Sales Value by Region (2025-2030)

5.1.4 Global Chitosan Hemostatic Material Sales Value by Region (%), (2019-2030)

5.2 Global Chitosan Hemostatic Material Sales Volume by Region

5.2.1 Global Chitosan Hemostatic Material Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Chitosan Hemostatic Material Sales Volume by Region (2019-2024)

5.2.3 Global Chitosan Hemostatic Material Sales Volume by Region (2025-2030)

5.2.4 Global Chitosan Hemostatic Material Sales Volume by Region (%), (2019-2030)

5.3 Global Chitosan Hemostatic Material Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Chitosan Hemostatic Material Sales Value, 2019-2030

5.4.2 North America Chitosan Hemostatic Material Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Chitosan Hemostatic Material Sales Value, 2019-2030

5.5.2 Europe Chitosan Hemostatic Material Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Chitosan Hemostatic Material Sales Value, 2019-2030

5.6.2 Asia Pacific Chitosan Hemostatic Material Sales Value by Region (%), 2023 VS 2030

5.7 South America

5.7.1 South America Chitosan Hemostatic Material Sales Value, 2019-2030

5.7.2 South America Chitosan Hemostatic Material Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Chitosan Hemostatic Material Sales Value, 2019-2030

5.8.2 Middle East & Africa Chitosan Hemostatic Material Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Chitosan Hemostatic Material Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Chitosan Hemostatic Material Sales Value

6.2.1 Key Countries/Regions Chitosan Hemostatic Material Sales Value, 2019-2030

6.2.2 Key Countries/Regions Chitosan Hemostatic Material Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Chitosan Hemostatic Material Sales Value, 2019-2030

6.3.2 United States Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Chitosan Hemostatic Material Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Chitosan Hemostatic Material Sales Value, 2019-2030

6.4.2 Europe Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Chitosan Hemostatic Material Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Chitosan Hemostatic Material Sales Value, 2019-2030

6.5.2 China Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

6.5.3 China Chitosan Hemostatic Material Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Chitosan Hemostatic Material Sales Value, 2019-2030

6.6.2 Japan Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Chitosan Hemostatic Material Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Chitosan Hemostatic Material Sales Value, 2019-2030

6.7.2 South Korea Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Chitosan Hemostatic Material Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Chitosan Hemostatic Material Sales Value, 2019-2030

6.8.2 Southeast Asia Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Chitosan Hemostatic Material Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Chitosan Hemostatic Material Sales Value, 2019-2030

6.9.2 India Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

6.9.3 India Chitosan Hemostatic Material Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Anscare

7.1.1 Anscare Company Information

7.1.2 Anscare Introduction and Business Overview

7.1.3 Anscare Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.1.4 Anscare Chitosan Hemostatic Material Product Offerings

7.1.5 Anscare Recent Development

7.2 Tricol Biomedical

7.2.1 Tricol Biomedical Company Information

7.2.2 Tricol Biomedical Introduction and Business Overview

7.2.3 Tricol Biomedical Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.2.4 Tricol Biomedical Chitosan Hemostatic Material Product Offerings

7.2.5 Tricol Biomedical Recent Development

7.3 Advamedica

7.3.1 Advamedica Company Information

7.3.2 Advamedica Introduction and Business Overview

7.3.3 Advamedica Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.3.4 Advamedica Chitosan Hemostatic Material Product Offerings

7.3.5 Advamedica Recent Development

7.4 Hemoflex

7.4.1 Hemoflex Company Information

7.4.2 Hemoflex Introduction and Business Overview

7.4.3 Hemoflex Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.4.4 Hemoflex Chitosan Hemostatic Material Product Offerings

7.4.5 Hemoflex Recent Development

7.5 Mermaid Medical

7.5.1 Mermaid Medical Company Information

7.5.2 Mermaid Medical Introduction and Business Overview

7.5.3 Mermaid Medical Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.5.4 Mermaid Medical Chitosan Hemostatic Material Product Offerings

7.5.5 Mermaid Medical Recent Development

7.6 Hemostasis

7.6.1 Hemostasis Company Information

7.6.2 Hemostasis Introduction and Business Overview

7.6.3 Hemostasis Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.6.4 Hemostasis Chitosan Hemostatic Material Product Offerings

7.6.5 Hemostasis Recent Development

7.7 Medcura

7.7.1 Medcura Company Information

7.7.2 Medcura Introduction and Business Overview

7.7.3 Medcura Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.7.4 Medcura Chitosan Hemostatic Material Product Offerings

7.7.5 Medcura Recent Development

7.8 BioPharm Med

7.8.1 BioPharm Med Company Information

7.8.2 BioPharm Med Introduction and Business Overview

7.8.3 BioPharm Med Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.8.4 BioPharm Med Chitosan Hemostatic Material Product Offerings

7.8.5 BioPharm Med Recent Development

7.9 MedTrade Products

7.9.1 MedTrade Products Company Information

7.9.2 MedTrade Products Introduction and Business Overview

7.9.3 MedTrade Products Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.9.4 MedTrade Products Chitosan Hemostatic Material Product Offerings

7.9.5 MedTrade Products Recent Development

7.10 Shijiazhuang Yishengtang Medical Product

7.10.1 Shijiazhuang Yishengtang Medical Product Company Information

7.10.2 Shijiazhuang Yishengtang Medical Product Introduction and Business Overview

7.10.3 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.10.4 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Product Offerings

7.10.5 Shijiazhuang Yishengtang Medical Product Recent Development

7.11 Biotemed

7.11.1 Biotemed Company Information

7.11.2 Biotemed Introduction and Business Overview

7.11.3 Biotemed Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.11.4 Biotemed Chitosan Hemostatic Material Product Offerings

7.11.5 Biotemed Recent Development

7.12 Haiyuan Hairun

7.12.1 Haiyuan Hairun Company Information

7.12.2 Haiyuan Hairun Introduction and Business Overview

7.12.3 Haiyuan Hairun Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.12.4 Haiyuan Hairun Chitosan Hemostatic Material Product Offerings

7.12.5 Haiyuan Hairun Recent Development

7.13 Yancheng Yankang Medical Equipment

7.13.1 Yancheng Yankang Medical Equipment Company Information

7.13.2 Yancheng Yankang Medical Equipment Introduction and Business Overview

7.13.3 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.13.4 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Product Offerings

7.13.5 Yancheng Yankang Medical Equipment Recent Development

7.14 Success Bio-Tech

7.14.1 Success Bio-Tech Company Information

7.14.2 Success Bio-Tech Introduction and Business Overview

7.14.3 Success Bio-Tech Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.14.4 Success Bio-Tech Chitosan Hemostatic Material Product Offerings

7.14.5 Success Bio-Tech Recent Development

7.15 Lanhine Medical

7.15.1 Lanhine Medical Company Information

7.15.2 Lanhine Medical Introduction and Business Overview

7.15.3 Lanhine Medical Chitosan Hemostatic Material Sales, Revenue, Price and Gross Margin (2019-2024)

7.15.4 Lanhine Medical Chitosan Hemostatic Material Product Offerings

7.15.5 Lanhine Medical Recent Development

8 Industry Chain Analysis

8.1 Chitosan Hemostatic Material Industrial Chain

8.2 Chitosan Hemostatic Material Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Chitosan Hemostatic Material Sales Model

8.5.2 Sales Channel

8.5.3 Chitosan Hemostatic Material Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Chitosan Hemostatic Material Market Trends

Table 2. Chitosan Hemostatic Material Market Drivers & Opportunity

Table 3. Chitosan Hemostatic Material Market Challenges

Table 4. Chitosan Hemostatic Material Market Restraints

Table 5. Global Chitosan Hemostatic Material Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Chitosan Hemostatic Material Revenue Market Share by Company (2019-2024)

Table 7. Global Chitosan Hemostatic Material Sales Volume by Company (2019-2024) & (Units)

Table 8. Global Chitosan Hemostatic Material Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Chitosan Hemostatic Material Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Chitosan Hemostatic Material Manufacturing Base and Headquarters

Table 11. Key Manufacturers Chitosan Hemostatic Material Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Chitosan Hemostatic Material

Table 13. Global Chitosan Hemostatic Material Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chitosan Hemostatic Material as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Chitosan Hemostatic Material Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Chitosan Hemostatic Material Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Chitosan Hemostatic Material Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Chitosan Hemostatic Material Sales Market Share in Value by Type (2019-2024)

Table 20. Global Chitosan Hemostatic Material Sales Market Share in Value by Type (2025-2030)

Table 21. Global Chitosan Hemostatic Material Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)

Table 22. Global Chitosan Hemostatic Material Sales Volume by Type (2019-2024) & (Units)

Table 23. Global Chitosan Hemostatic Material Sales Volume by Type (2025-2030) & (Units)

Table 24. Global Chitosan Hemostatic Material Sales Market Share in Volume by Type (2019-2024)

Table 25. Global Chitosan Hemostatic Material Sales Market Share in Volume by Type (2025-2030)

Table 26. Global Chitosan Hemostatic Material Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Chitosan Hemostatic Material Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Chitosan Hemostatic Material Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Chitosan Hemostatic Material Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Chitosan Hemostatic Material Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Chitosan Hemostatic Material Sales Market Share in Value by Application (2019-2024)

Table 32. Global Chitosan Hemostatic Material Sales Market Share in Value by Application (2025-2030)

Table 33. Global Chitosan Hemostatic Material Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)

Table 34. Global Chitosan Hemostatic Material Sales Volume by Application (2019-2024) & (Units)

Table 35. Global Chitosan Hemostatic Material Sales Volume by Application (2025-2030) & (Units)

Table 36. Global Chitosan Hemostatic Material Sales Market Share in Volume by Application (2019-2024)

Table 37. Global Chitosan Hemostatic Material Sales Market Share in Volume by Application (2025-2030)

Table 38. Global Chitosan Hemostatic Material Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Chitosan Hemostatic Material Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Chitosan Hemostatic Material Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)

Table 41. Global Chitosan Hemostatic Material Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Chitosan Hemostatic Material Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Chitosan Hemostatic Material Sales Value by Region (2019-2024) & (%)

Table 44. Global Chitosan Hemostatic Material Sales Value by Region (2025-2030) & (%)

Table 45. Global Chitosan Hemostatic Material Sales Volume by Region (Units): 2019 VS 2023 VS 2030

Table 46. Global Chitosan Hemostatic Material Sales Volume by Region (2019-2024) & (Units)

Table 47. Global Chitosan Hemostatic Material Sales Volume by Region (2025-2030) & (Units)

Table 48. Global Chitosan Hemostatic Material Sales Volume by Region (2019-2024) & (%)

Table 49. Global Chitosan Hemostatic Material Sales Volume by Region (2025-2030) & (%)

Table 50. Global Chitosan Hemostatic Material Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Chitosan Hemostatic Material Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Chitosan Hemostatic Material Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Chitosan Hemostatic Material Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Chitosan Hemostatic Material Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Chitosan Hemostatic Material Sales Volume, (2019-2024) & (Units)

Table 56. Key Countries/Regions Chitosan Hemostatic Material Sales Volume, (2025-2030) & (Units)

Table 57. Anscare Company Information

Table 58. Anscare Introduction and Business Overview

Table 59. Anscare Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Anscare Chitosan Hemostatic Material Product Offerings

Table 61. Anscare Recent Development

Table 62. Tricol Biomedical Company Information

Table 63. Tricol Biomedical Introduction and Business Overview

Table 64. Tricol Biomedical Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Tricol Biomedical Chitosan Hemostatic Material Product Offerings

Table 66. Tricol Biomedical Recent Development

Table 67. Advamedica Company Information

Table 68. Advamedica Introduction and Business Overview

Table 69. Advamedica Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Advamedica Chitosan Hemostatic Material Product Offerings

Table 71. Advamedica Recent Development

Table 72. Hemoflex Company Information

Table 73. Hemoflex Introduction and Business Overview

Table 74. Hemoflex Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Hemoflex Chitosan Hemostatic Material Product Offerings

Table 76. Hemoflex Recent Development

Table 77. Mermaid Medical Company Information

Table 78. Mermaid Medical Introduction and Business Overview

Table 79. Mermaid Medical Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Mermaid Medical Chitosan Hemostatic Material Product Offerings

Table 81. Mermaid Medical Recent Development

Table 82. Hemostasis Company Information

Table 83. Hemostasis Introduction and Business Overview

Table 84. Hemostasis Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Hemostasis Chitosan Hemostatic Material Product Offerings

Table 86. Hemostasis Recent Development

Table 87. Medcura Company Information

Table 88. Medcura Introduction and Business Overview

Table 89. Medcura Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Medcura Chitosan Hemostatic Material Product Offerings

Table 91. Medcura Recent Development

Table 92. BioPharm Med Company Information

Table 93. BioPharm Med Introduction and Business Overview

Table 94. BioPharm Med Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. BioPharm Med Chitosan Hemostatic Material Product Offerings

Table 96. BioPharm Med Recent Development

Table 97. MedTrade Products Company Information

Table 98. MedTrade Products Introduction and Business Overview

Table 99. MedTrade Products Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. MedTrade Products Chitosan Hemostatic Material Product Offerings

Table 101. MedTrade Products Recent Development

Table 102. Shijiazhuang Yishengtang Medical Product Company Information

Table 103. Shijiazhuang Yishengtang Medical Product Introduction and Business Overview

Table 104. Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Product Offerings

Table 106. Shijiazhuang Yishengtang Medical Product Recent Development

Table 107. Biotemed Company Information

Table 108. Biotemed Introduction and Business Overview

Table 109. Biotemed Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Biotemed Chitosan Hemostatic Material Product Offerings

Table 111. Biotemed Recent Development

Table 112. Haiyuan Hairun Company Information

Table 113. Haiyuan Hairun Introduction and Business Overview

Table 114. Haiyuan Hairun Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Haiyuan Hairun Chitosan Hemostatic Material Product Offerings

Table 116. Haiyuan Hairun Recent Development

Table 117. Yancheng Yankang Medical Equipment Company Information

Table 118. Yancheng Yankang Medical Equipment Introduction and Business Overview

Table 119. Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Product Offerings

Table 121. Yancheng Yankang Medical Equipment Recent Development

Table 122. Success Bio-Tech Company Information

Table 123. Success Bio-Tech Introduction and Business Overview

Table 124. Success Bio-Tech Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Success Bio-Tech Chitosan Hemostatic Material Product Offerings

Table 126. Success Bio-Tech Recent Development

Table 127. Lanhine Medical Company Information

Table 128. Lanhine Medical Introduction and Business Overview

Table 129. Lanhine Medical Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Lanhine Medical Chitosan Hemostatic Material Product Offerings

Table 131. Lanhine Medical Recent Development

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Chitosan Hemostatic Material Downstream Customers

Table 135. Chitosan Hemostatic Material Distributors List

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Chitosan Hemostatic Material Product Picture

Figure 2. Global Chitosan Hemostatic Material Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Chitosan Hemostatic Material Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Chitosan Hemostatic Material Sales Volume (2019-2030) & (Units)

Figure 5. Global Chitosan Hemostatic Material Sales Price (2019-2030) & (US$/Unit)

Figure 6. Chitosan Hemostatic Material Report Years Considered

Figure 7. Global Chitosan Hemostatic Material Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Chitosan Hemostatic Material Players Sales Volume Ranking (2023) & (US$ Million)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chitosan Hemostatic Material Revenue in 2023

Figure 10. Chitosan Hemostatic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Hemostatic Gauze Picture

Figure 12. Hemostatic Powder Picture

Figure 13. Hemostatic Sponge Picture

Figure 14. Others Picture

Figure 15. Global Chitosan Hemostatic Material Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Chitosan Hemostatic Material Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Chitosan Hemostatic Material Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)

Figure 18. Global Chitosan Hemostatic Material Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Chitosan Hemostatic Material Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Surgery

Figure 21. Product Picture of First Aid

Figure 22. Global Chitosan Hemostatic Material Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Chitosan Hemostatic Material Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Chitosan Hemostatic Material Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)

Figure 25. Global Chitosan Hemostatic Material Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Chitosan Hemostatic Material Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Chitosan Hemostatic Material Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Chitosan Hemostatic Material Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 30. Europe Chitosan Hemostatic Material Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Chitosan Hemostatic Material Sales Value by Region (%), 2023 VS 2030

Figure 33. South America Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 34. South America Chitosan Hemostatic Material Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Chitosan Hemostatic Material Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Chitosan Hemostatic Material Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Chitosan Hemostatic Material Sales Volume (%), (2019-2030)

Figure 39. United States Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Chitosan Hemostatic Material Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Chitosan Hemostatic Material Sales Value by Application (%), 2023 VS 2030

Figure 45. China Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

Figure 47. China Chitosan Hemostatic Material Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Chitosan Hemostatic Material Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Chitosan Hemostatic Material Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Chitosan Hemostatic Material Sales Value by Application (%), 2023 VS 2030

Figure 57. India Chitosan Hemostatic Material Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Chitosan Hemostatic Material Sales Value by Type (%), 2023 VS 2030

Figure 59. India Chitosan Hemostatic Material Sales Value by Application (%), 2023 VS 2030

Figure 60. Chitosan Hemostatic Material Industrial Chain

Figure 61. Chitosan Hemostatic Material Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Chitosan Hemostatic Material market? zhanKai

The top companies in the global Chitosan Hemostatic Material market are Anscare、Tricol Biomedical、Advamedica.

Related Reports

Global Chitosan Hemostatic Material Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chitosan Hemostatic Material market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 170
USD 4900.00
(Single User License)
Global Chitosan Hemostatic Material Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Chitosan Hemostatic Material market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 94
USD 4250.00
(Single User License)
Chitosan Hemostatic Material- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chitosan Hemostatic Material was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 119
USD 3950.00
(Single User License)
Global Chitosan Hemostatic Material Market Research Report 2026
The global Chitosan Hemostatic Material market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 124
USD 2900.00
(Single User License)
Global Chitosan Hemostatic Material Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chitosan Hemostatic Material market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 151
USD 4900.00
(Single User License)
Global Chitosan Hemostatic Material Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chitosan Hemostatic Material market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 94
USD 4250.00
(Single User License)
Chitosan Hemostatic Material - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chitosan Hemostatic Material was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 122
USD 3950.00
(Single User License)
Global Chitosan Hemostatic Material Market Research Report 2025
The global market for Chitosan Hemostatic Material was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 97
USD 2900.00
(Single User License)
Global Chitosan Hemostatic Material Market Insights, Forecast to 2030
Chitosan hemostatic materials are a type of biomedical materials based on natural chitosan, which are mainly used to accelerate hemostasis and promote wound healing. Chitosan is a natural polysaccharide extracted from the shells of crustaceans, which has good biocompatibility, antibacterial and degradability. Its hemostatic mechanism includes promoting platelet aggregation, accelerating blood clot formation and constricting blood vessels. Chitosan hemostatic materials are widely used in surgical operations, trauma emergency treatment and the treatment of chronic trauma, and have multiple functions of rapid hemostasis, reducing infection and promoting tissue repair.
Published Date: 2024-10-17
Pages: 160
USD 4900.00
(Single User License)
Global Chitosan Hemostatic Material Market Research Report 2024
Chitosan hemostatic materials are a type of biomedical materials based on natural chitosan, which are mainly used to accelerate hemostasis and promote wound healing. Chitosan is a natural polysaccharide extracted from the shells of crustaceans, which has good biocompatibility, antibacterial and degradability. Its hemostatic mechanism includes promoting platelet aggregation, accelerating blood clot formation and constricting blood vessels. Chitosan hemostatic materials are widely used in surgical operations, trauma emergency treatment and the treatment of chronic trauma, and have multiple functions of rapid hemostasis, reducing infection and promoting tissue repair.
Published Date: 2024-10-17
Pages: 90
USD 2900.00
(Single User License)

Global Chitosan Hemostatic Material Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Chitosan Hemostatic Material market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 170
USD 4900.00 (Single User License)
Global Chitosan Hemostatic Material Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Chitosan Hemostatic Material market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 94
USD 4250.00 (Single User License)
Chitosan Hemostatic Material- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Chitosan Hemostatic Material was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 119
USD 3950.00 (Single User License)
Global Chitosan Hemostatic Material Market Research Report 2026
The global Chitosan Hemostatic Material market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 124
USD 2900.00 (Single User License)
Global Chitosan Hemostatic Material Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Chitosan Hemostatic Material market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 151
USD 4900.00 (Single User License)
Global Chitosan Hemostatic Material Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Chitosan Hemostatic Material market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 94
USD 4250.00 (Single User License)
Chitosan Hemostatic Material - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Chitosan Hemostatic Material was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 122
USD 3950.00 (Single User License)
Global Chitosan Hemostatic Material Market Research Report 2025
The global market for Chitosan Hemostatic Material was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 97
USD 2900.00 (Single User License)
Global Chitosan Hemostatic Material Market Insights, Forecast to 2030
Chitosan hemostatic materials are a type of biomedical materials based on natural chitosan, which are mainly used to accelerate hemostasis and promote wound healing. Chitosan is a natural polysaccharide extracted from the shells of crustaceans, which has good biocompatibility, antibacterial and degradability. Its hemostatic mechanism includes promoting platelet aggregation, accelerating blood clot formation and constricting blood vessels. Chitosan hemostatic materials are widely used in surgical operations, trauma emergency treatment and the treatment of chronic trauma, and have multiple functions of rapid hemostasis, reducing infection and promoting tissue repair.
Published: 2024-10-17
Pages: 160
USD 4900.00 (Single User License)
Global Chitosan Hemostatic Material Market Research Report 2024
Chitosan hemostatic materials are a type of biomedical materials based on natural chitosan, which are mainly used to accelerate hemostasis and promote wound healing. Chitosan is a natural polysaccharide extracted from the shells of crustaceans, which has good biocompatibility, antibacterial and degradability. Its hemostatic mechanism includes promoting platelet aggregation, accelerating blood clot formation and constricting blood vessels. Chitosan hemostatic materials are widely used in surgical operations, trauma emergency treatment and the treatment of chronic trauma, and have multiple functions of rapid hemostasis, reducing infection and promoting tissue repair.
Published: 2024-10-17
Pages: 90
USD 2900.00 (Single User License)